Hemophilia B Genterapy AMT-061 Safe, Effective, Trial Data Show

Hemophilia B Genterapy AMT-061 Safe, Effective, Trial Data Show

Hemophilia Nyheder i dag

Billede

Please enable the javascript to submit this form

Støttet af uddannelsesstipendier fra Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics og uniQure, Inc.

Væsentlig SSL